Wuhan Competitors

Delisted . USA . 
Stock . Wuhan General Gr
WUHNDelisted Stock  USD 0.0004  0.00  0.00%   
Wuhan General Gr competes with Cannara Biotech, Avicanna, Acreage Holdings, Cronos, and Aurora Cannabis; as well as few others. The company conducts business under Pharmaceuticals sector and is part of Health Care industry. Analyzing Wuhan General competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Wuhan General to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Wuhan General competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00050.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00040.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Wuhan General. Your research has to be compared to or analyzed against Wuhan General's peers to derive any actionable benefits. When done correctly, Wuhan General's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Wuhan General Gr.

Wuhan General Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Wuhan General and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Wuhan and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Wuhan General Gr does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ACRDF
+ 0.49
BBRRF
CBWTF
+ 0.38
BBRRF
BBRRF
+ 0.22
AVCNF
CBWTF
+ 0.2
BIOIF
ACRDF
+ 0.14
BIOIF
ACRDF
+ 0.14
AUSAF
  
High negative correlations   
BBRRF
- 0.49
LOVFF
ACRDF
- 0.46
LOVFF
CBWTF
- 0.4
ALEAF
AVCNF
- 0.4
BIOIF
ACRDF
- 0.34
ALEAF
CBWTF
- 0.29
AVCNF

Risk-Adjusted Indicators

There is a big difference between Wuhan Pink Sheet performing well and Wuhan General Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Wuhan General's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BIOIF  15.20  5.23  0.00 (0.92) 0.00 
 0.00 
 21.62 
(32.73)
 264.86 
HCANF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LOVFF  3.34  0.64  0.08  1.86  3.31 
(10.68)
 15.69 
(6.78)
 36.67 
AVCNF  4.76 (0.19) 0.00  0.28  0.00 
 0.00 
 15.00 
(13.33)
 45.00 
BBRRF  6.78  0.29  0.02 (0.30) 7.81 
(10.94)
 20.00 
(16.67)
 52.37 
ALEAF  0.02  0.00  0.00  0.01  0.00 
 0.00 
 0.00 
 0.00 
 0.67 
CBWTF  5.06  0.15  0.02 (0.17) 5.41 
(6.56)
 10.34 
(8.87)
 23.67 
FLWPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AUSAF  298.46  153.08  0.00 (1.44) 0.00 
 0.00 
 0.00 
 0.00 
 10,099 
ACRDF  8.79 (0.02) 0.00  0.01  10.44 
(15.32)
 21.43 
(17.65)
 75.71 
All Fundamental Data

Wuhan General Competitive Analysis

The better you understand Wuhan General competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Wuhan General's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Wuhan General's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
WUHN BIOIF HCANF LOVFF AVCNF BBRRF ALEAF CBWTF ACRDF HEXO
 0.00 
 0.0004 
Wuhan
 94.74 
 0.01 
Biome
 0.00 
 0.0001 
Halo
 14.58 
 0.55 
Cannara
 13.04 
 0.20 
Avicanna
 4.42 
 0.01 
Blueberries
 0.00 
 0.02 
Aleafia
 8.33 
 0.03 
Auxly
 9.09 
 0.12 
Acreage
 0.00 
 0.71 
Hexo
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Very steady
Out of control
Out of control
Out of control
Somewhat reliable
Out of control
Out of control
Very steady
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
Weak
Very Weak
Very Weak
Very Weak
Weak
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Average
Quite High
Low
Low
Very High
Dangerous
Quite High
Quite High
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Not Rated
Current Ratio
1.1
0.53
2.22
2.13
0.9
0.41
1.2
2.58
1.5
0.99
Net Asset
286.58 M
11.07 M
104.8 M
125.62 M
22.3 M
3.59 M
N/A
450.42 M
491.55 M
680.95 M
Profit Margin
-0.13
N/A
N/A
0.0717
N/A
N/A
-1.6
-1.34
-0.36
-2.2
EBITDA
379.92 K
313.61 K
(89.2 M)
8.14 M
(15.13 M)
(4.05 M)
(16.57 M)
(18.3 M)
(21.13 M)
(257.63 M)
Operating Margin
-0.0277
N/A
-1.27
0.15
-2.11
-14.36
-0.69
-0.52
-0.0205
-1.2
Current Valuation
3.05 M
2.98 M
17.62 M
94.03 M
20.15 M
3.89 M
54.76 M
146.85 M
326.65 M
191.06 M
Price To Book
0.0411
1.1
0.0053
1.37
9.32
132.07
1.11
0.18
0.8
0.41
Retained Earnings
15 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(1.84 B)
Current Asset
197 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
359.35 M
Beta
1.94
0.41
1.83
1.52
1.94
1.36
1.67
0.77
2.96
2.13
Number Of Employees
700
5
276
9
124
23
162
558
1.09 K
40
Shares Outstanding
33.93 M
112.42 M
10.31 M
877.48 M
74.52 M
163.81 M
403.04 M
913.01 M
34.04 M
44 M
Cash Flow From Operations
(21.86 M)
(1.84 M)
(35.23 M)
(6.08 M)
(11.66 M)
(1.68 M)
(32.66 M)
(49.63 M)
(40.53 M)
(116.69 M)
Total Debt
118.8 M
3.51 M
2.39 M
46.19 M
415.83 K
1.57 M
44.93 M
151.36 M
169.15 M
251.52 M
Return On Equity
-0.0878
-4.37
-0.97
0.0434
-1.69
-2.12
-1.97
-0.81
-0.48
-1.06
Z Score
N/A
N/A
N/A
0.6
33.0
-2.1
N/A
N/A
N/A
-4.79
Return On Asset
-0.005
-0.0844
-0.16
0.0327
-0.22
-0.26
-0.24
-0.0868
-0.0062
-0.15
Number Of Shares Shorted
12.62 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
971.71 K
Book Value Per Share
2.34
-0.024
7.78
0.077
0.038
N/A
0.068
0.12
1.41
3.24
Current Liabilities
179 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
50.65 M
Total Asset
286.58 M
11.07 M
104.8 M
125.62 M
22.3 M
3.59 M
N/A
450.42 M
491.55 M
680.95 M
Debt To Equity
1.11
1.45
0.24
0.49
0.31
4.08
2.32
1.2
1.25
0.99
Short Ratio
0.15
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.02
Target Price
N/A
N/A
123.1
N/A
N/A
N/A
N/A
N/A
2.56
0.7
Shares Owned By Institutions
N/A
N/A
N/A
N/A
N/A
N/A
0.01
3.18
N/A
7.57
Market Capitalization
3.05 M
1.3 M
164.26 K
63.27 M
22.99 M
4.68 M
22.57 M
14.61 M
75.24 M
31.24 M
Price To Earning
-0.06
0.48
N/A
85.0
N/A
13.85
N/A
N/A
N/A
-16.42
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
0.0478
2.0
0.013
1.81
4.51
23.72
0.54
0.16
0.44
0.43
Net Income
(10.59 M)
(139.93 K)
(94.61 M)
2.31 M
(16.77 M)
(5.15 M)
(165.72 M)
(33.74 M)
(73.16 M)
(1.11 B)
Earnings Per Share
-0.35
-0.15
-3.17
0.15
-0.26
-0.026
-0.39
-0.059
-0.64
-2.77
Shares Owned By Insiders
N/A
47.31
0.13
47.54
22.52
68.53
1.51
21.04
10.81
3.02
Revenue
80.38 M
N/A
36.18 M
35.84 M
3.27 M
138.75 K
36.47 M
83.83 M
188.86 M
191.1 M
Working Capital
18 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(63.43 M)
Cash And Equivalents
18.79 M
2.1 M
1.57 M
3.88 M
685.94 K
467.13 K
5.46 M
20.53 M
32.64 M
14.22 M
Cash Per Share
0.55
0.02
0.14
N/A
0.01
N/A
0.01
0.02
277.53
0.03
Gross Profit
14.54 M
1.13 M
4.45 M
17.33 M
2.83 M
(245.45 K)
(9.56 M)
19.29 M
95.88 M
(75.67 M)
Day Typical Price
4.0E-4
0.0074
1.0E-4
0.55
0.2
0.0097
0.0151
0.0237
0.12
0.71
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
0.35
N/A
0.27
0.21
N/A
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
0.0039
N/A
0.007
0.03
N/A
Daily Balance Of Power
0.0
9.2 T
0.0
9.2 T
(9,223,372,036,855)
(0.13)
0.0
0.2857
0.3333
0.0
Period Momentum Indicator
N/A
0.0036
N/A
0.07
(0.03)
(0.0005)
N/A
0.002
0.01
N/A
Rate Of Daily Change
1.0
1.95
1.0
1.15
0.87
0.96
1.0
1.08
1.09
1.0
Day Median Price
4.0E-4
0.0074
1.0E-4
0.55
0.2
0.0092
0.0151
0.0225
0.13
0.71
Price Action Indicator
N/A
0.0018
N/A
0.035
(0.01)
0.0014
N/A
0.0045
N/A
N/A
Coefficient Of Variation
866.02
758.71
N/A
922.57
(4,055)
3582.18
812.4
4527.96
29751.74
(948.47)
Mean Deviation
42.23
15.2
N/A
3.34
4.76
6.78
0.0199
5.06
8.79
3.85
Jensen Alpha
18.11
5.23
N/A
0.6371
(0.19)
0.2914
(0.0002)
0.1487
(0.02)
(0.73)
Total Risk Alpha
13.57
4.02
N/A
0.4766
(0.43)
(0.01)
(0)
(0.05)
(0.34)
(0.89)
Sortino Ratio
N/A
N/A
N/A
0.0824
N/A
0.0235
N/A
0.0164
9.0E-4
N/A
Downside Variance
N/A
N/A
N/A
57.12
N/A
112.37
N/A
44.07
218.29
N/A
Standard Deviation
154.93
38.8
N/A
6.04
7.98
10.08
0.0821
6.39
13.5
6.6
Kurtosis
62.19
20.9
N/A
4.3
2.33
0.8336
66.0
0.1805
2.71
10.06
Potential Upside
25.0
21.62
N/A
15.69
15.0
20.0
N/A
10.34
21.43
5.88
Treynor Ratio
(1.75)
(0.92)
N/A
1.86
0.279
(0.30)
0.0071
(0.17)
0.0148
(0.67)
Maximum Drawdown
1334.03
264.86
N/A
36.67
45.0
52.37
0.6667
23.67
75.71
56.99
Variance
24003.67
1505.2
N/A
36.49
63.75
101.51
0.0067
40.87
182.38
43.62
Market Risk Adjusted Performance
(1.74)
(0.91)
N/A
1.87
0.289
(0.29)
0.0171
(0.16)
0.0248
(0.66)
Risk Adjusted Performance
0.102
0.1149
N/A
0.0951
(0.01)
0.0315
0.011
0.0264
0.0121
(0.08)
Skewness
7.78
4.33
N/A
1.34
0.4477
0.4825
8.12
0.4303
0.5885
0.6079
Semi Deviation
N/A
N/A
N/A
3.31
N/A
7.81
N/A
5.41
10.44
N/A
Information Ratio
0.1153
0.131
N/A
0.1031
(0.03)
0.0247
(0.27)
0.017
0.001
(0.11)
Value At Risk
(50.00)
(32.73)
N/A
(6.78)
(13.33)
(16.67)
N/A
(8.87)
(17.65)
(10.47)
Expected Short fall
N/A
N/A
N/A
(10.68)
N/A
(10.94)
N/A
(6.56)
(15.32)
N/A
Downside Deviation
N/A
N/A
N/A
7.56
N/A
10.6
N/A
6.64
14.77
N/A
Semi Variance
N/A
N/A
N/A
10.97
N/A
61.0
N/A
29.24
109.1
N/A

Wuhan General Competition Performance Charts

Five steps to successful analysis of Wuhan General Competition

Wuhan General's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Wuhan General Gr in relation to its competition. Wuhan General's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Wuhan General in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Wuhan General's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Wuhan General Gr, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Wuhan General position

In addition to having Wuhan General in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Video Games Thematic Idea Now

Video Games
Video Games Theme
Companies that are involved in the building and marketing of video games or gaming software. The Video Games theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Video Games Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Wuhan Pink Sheet

If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY